Biomedcode Hellas SA

Services:

Humanised mouse models
Specialised phenotyping
Preclinical testing
Cellular and molecular assays
Histology
PK/PD services
Customised services

Address:
34 Alexander Fleming Street
16672 Vari-Athens
Greece
Web: www.biomedcode.com

Biomedcode Hellas SA

Biomedcode Hellas SA is a highly innovative contract research organisation (CRO) offering a diverse array of advanced preclinical evaluation platforms based on a unique collection of spontaneous and induced humanised mouse models that closely recapitulate the pathology and complexity of human inflammatory diseases.

Combining scientific consultation with custom-made solutions, since 2006, Biomedcode has provided preclinical drug evaluation services to more than 110 pharmaceutical and biotech companies worldwide including Europe, the United States and Asia, thus contributing to the successful preclinical evaluation and IND filing of a number of therapeutics.

Biomedcode also maintains a highly active R&D programme that aims to generate and standardise novel humanised disease models to be used as preclinical evaluation platforms as well as advanced tools for the study of disease mechanisms.

Matching News

Event October 2, 2024

The INFRAPLUS Project Successfully Launched in Munich

The INFRAPLUS’s kick-off took place over two productive days in Munich. With lively discussions and concrete plans, we have set the stage for INFRAFRONTIER’s expansion in state-of-the-art in vivo models, innovative in vitro models, preclinical services, and data analysis. All set to get started!

Scientific Publication September 10, 2023

Targeting Senescence and Inflammation in Chronic Destructive TNF-driven Joint Pathology

Biomedcode’s Tg197 human TNF transgenic mouse model of chronic destructive arthritis provides new insights on how combination treatment with Dasatinib and low-dose anti-TNF leads to synergistic senolytic effects on chondrocytes and effective treatment of arthritis.

Scientific Publication August 7, 2023

Α Humanised RANKL Transgenic Mouse Model of Progestin-Induced Mammary Carcinogenesis for Evaluation of Novel Therapeutics

A Biomedcode collaboration has developed a human-RANKL dependent breast cancer mouse model aiming to study disease mechanisms and establish preclinical platforms for the evaluation of human therapeutics targeting cancer.

Scientific Publication July 24, 2023

New INFRAFRONTIER Article Published in Journal Mammalian Genome

A new publication of INFRAFRONTIER in Mammalian Genome is available on line now. Get an overview of the latest INFRAFRONTIER advancements, including services, resources, and technical developments.

Highlight January 29, 2020

Trans-national Access Call – Specialised phenotyping: Mutant mice under inflammatory disease conditions

In the INFRAFRONTIER2020 specialised phenotyping program, INFRAFRONTIER partner institutions offer the indepth characterisation of mouse mutants for interested biomedical researchers all around the globe. The call is free of charge for the user, concerning scientific service and expertise.